NCT01609036终止不适用
An Observational Phase IV Non Interventional Study in Patients With Advanced Follicular Lymphoma (III-IV) Evaluating the Safety of Maintenance Therapy With Rituximab After 8 Cycles of Rituximab in Combination With Chemotherapy as Induction Therapy in Previously Untreated Patients in Greece.
适应症
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 入组人数
- 3
- 主要终点
- Safety: Incidence of adverse events
研究概览
简要总结
This observational study will evaluate the safety and efficacy of MabThera/Rituxan (rituximab) in previously untreated patients with follicular lymphoma. Data will be collected for 3 years
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Adult patients, >/=18 years
- •Patients with previously untreated follicular lymphoma (stage III-IV) according to the approved summary of product characteristics (SPC)
排除标准
- •Contraindications to MabThera/Rituxan therapy according to the approved SPC
结局指标
主要结局
Safety: Incidence of adverse events
时间窗: 3 years
次要结局
- Overall survival(3 years)
- Event-free survival(3 years)
- Progression-free survival(3 years)
研究者
相似试验
已完成
不适用
An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC)Lymphocytic Leukemia, ChronicNCT01224093Hoffmann-La Roche219
已完成
不适用
A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic LeukemiaLymphocytic Leukemia, ChronicNCT01609023Hoffmann-La Roche67
已完成
不适用
An Observational Study of Rituximab in Combination With Methotrexate in Participants With Active Rheumatoid ArthritisRheumatoid ArthritisNCT01283399Hoffmann-La Roche79
已完成
不适用
An Observational Study of First-Line Maintenance Rituximab (MabThera/Rituxan) in Participants With Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT01684865Hoffmann-La Roche22
已完成
2 期
A Study of MabThera/Rituxan (Rituximab) in Patients With Non-Bulky Follicular Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaNCT01392716Hoffmann-La Roche48